VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
VINC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
VINCVincerx Pharma, Inc.
$0.01$66475
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksVINCQuarterly Financials

Vincerx Pharma, Inc. (VINC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Vincerx Pharma, Inc. (VINC) quarterly income statement — complete revenue, gross profit & net income history

VINC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20Q3'20Q2'20
Sales/Revenue01.07M0001.31M0000000000127K-1.4M00
Revenue Growth %--18.72%-----------100%100%------
Cost of Goods Sold000270K264K258K254K249K154K241K236K232K230K343K48K-26K0000
COGS % of Revenue-----19.63%--------------
Gross Profit0534K0-270K-264K1.06M-254K-249K-154K-241K-236K-232K-230K-343K-48K26K127K-1.4M00
Gross Margin %-50%---80.37%----------100%100%--
Gross Profit Growth %100%-49.43%100%-8.43%-71.43%538.17%-7.63%-7.33%33.04%29.74%-391.67%-992.31%-281.1%75.5%--429.11%---
Operating Expenses3.33M8.83M7.79M7.37M7.21M5.53M10.32M11.66M15.1M15.42M15.59M18.46M21.63M17.71M17.93M17.39M9.63M10.37M305K33K
OpEx % of Revenue-826.4%---421.08%----------7578.74%-740.86%--
Selling, General & Admin2.32M5.56M3.88M3.61M2.92M1.82M3.52M3.79M4.51M4.05M4.53M4.72M5.66M5.37M5.72M6.7M4.79M3.26M305K33K
SG&A % of Revenue-520.41%---138.51%----------3772.44%-232.57%--
Research & Development1.02M3.27M3.91M3.75M4.29M3.46M6.8M7.87M10.59M11.37M11.07M13.74M15.97M12.34M12.21M10.7M4.83M7.12M00
R&D % of Revenue-305.99%---262.94%----------3806.3%-508.29%--
Other Operating Expenses00000258K230K300K274K1000K-103K1000K-8K-21K13K002K-2K0
Operating Income-3.33M-8.83M-7.79M-7.37M-7.48M-5.53M-10.32M-11.66M-15.1M-15.42M-16.9M-19.62M-21.63M-17.71M-17.93M-17.39M-9.63M-10.37M-305K-33K
Operating Margin %--826.4%----421.08%-----------7578.74%740.86%--
Operating Income Growth %55.42%-59.52%24.46%36.83%50.47%64.13%38.96%40.58%30.18%12.9%5.74%-12.82%-124.7%-70.72%-5779.02%-52606.06%-240525%-25203.12%--
EBITDA-3.33M-8.54M-7.52M-7.1M-7.21M-5.28M-10.06M-11.41M-14.95M-15.18M-16.66M-19.39M-21.4M-17.36M-17.88M-17.42M-9.65M-5M00
EBITDA Margin %--800.09%----401.45%-----------7598.43%357.14%--
EBITDA Growth %53.78%-61.99%25.29%37.81%51.73%65.25%39.62%41.15%30.15%12.57%6.81%-11.32%-121.73%-247.28%------
D&A (Non-Cash Add-back)0281K275K270K264K258K254K249K154K241K236K232K230K343K48K-26K-25K5.37M305K33K
EBIT-3.33M-8.83M-7.79M-7.37M-7.48M-5.53M-10.32M-12.06M-15.41M-15.42M-15.59M-18.46M-21.63M-17.71M-17.93M-17.39M-9.63M-15.51M-305K-33K
Net Interest Income062K154K157K99K198K260K327K466K460K204K000000000
Interest Income062K154K157K99K198K260K327K466K460K204K000000000
Interest Expense00000000000000000000
Other Income/Expense-1.67M832K-50K5.56M-4.95M583K602K509K758K1.78M22K1.2M5.2M11.23M-6.59M15.36M3.35M-6K-2K0
Pretax Income-5M-7.99M-7.84M-1.81M-12.43M-4.95M-9.71M-11.15M-14.34M-13.64M-16.88M-18.42M-16.42M-6.47M-24.52M-2.03M-6.28M-10.38M-307K-33K
Pretax Margin %--748.5%----376.71%-----------4941.73%741.29%--
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-5M-7.99M-7.84M-1.81M-12.43M-4.95M-9.71M-11.15M-13.58M-5.46M-16.86M-17.22M-11.22M-6.47M-24.52M-2.03M-6.28M-10.38M-307K-33K
Net Margin %--748.5%----376.71%-----------4941.73%741.29%--
Net Income Growth %59.77%-61.49%19.27%83.79%8.5%9.31%42.37%35.24%-21.05%15.67%31.26%-746.56%-78.79%37.64%-7888.27%-6063.64%-156800%-25217.75%--
Net Income (Continuing)-5M-7.99M-7.84M-1.81M-12.43M-4.95M-9.71M-11.15M-14.34M-13.64M-16.88M-18.42M-16.42M-6.47M-24.52M-2.03M-6.28M-10.38M-307K-33K
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.964.22-1.41-0.32-2.11-0.84-1.65-1.97-2.51-2.34-2.90-3.18-2.85-1.13-5.03-0.45-1.66-11.24-0.22-0.02
EPS Growth %54.5%602.38%14.55%83.76%15.94%64.1%43.1%38.05%11.93%-107.08%42.35%-606.67%-71.69%89.95%-2186.36%-1782.85%--39200.7%--
EPS (Basic)-0.964.22-1.41-0.32-2.11-0.84-1.65-1.97-2.51-2.34-2.90-3.18-2.85-1.13-5.03-0.45-1.66-11.24-0.22-0.02
Diluted Shares Outstanding5.23M5.23M5.57M5.57M5.9M5.9M5.89M5.87M5.84M5.83M5.81M5.79M5.76M5.75M4.88M4.51M3.79M1.45M1.4M1.38M
Basic Shares Outstanding5.23M5.23M5.57M5.57M5.9M5.9M5.89M5.87M5.84M5.83M5.81M5.79M5.76M5.75M4.88M4.51M3.79M1.45M1.4M1.38M
Dividend Payout Ratio--------------------